STC Biologics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • STC Biologics's estimated annual revenue is currently $5.9M per year.(i)
  • STC Biologics's estimated revenue per employee is $155,000

Employee Data

  • STC Biologics has 38 Employees.(i)
  • STC Biologics grew their employee count by -12% last year.

STC Biologics's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Chief Development OfficerReveal Email/Phone
3
Head Cell line & Upstream DevelopmentReveal Email/Phone
4
Associate Director, Quality ControlReveal Email/Phone
5
Associate II DSPReveal Email/Phone
6
Upstream SupervisorReveal Email/Phone
7
Senior ScientistReveal Email/Phone
8
Research Associate, Analytical DevelopmentReveal Email/Phone
9
Upstream Supervisor Manufacturing at STC Biologics, Inc.Reveal Email/Phone
10
Analytical development leadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is STC Biologics?

STC Biologics Inc. is a biotech company located in Cambridge MA specializing in the development of biologic drugs with a focus on biosimilars. STC scientist are experts in analytics driven process development. Our strategy is to partner with various pharmaceutical and biotechnology companies to expedite drug development and to solve all hurdles in analytical development and process development. Specialties drug development from target selection to IND/CTA filling and BLA/MAA, biologics process development, analytics driven process development, biosimilar development

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M383%N/A
#2
$4.3M38N/AN/A
#3
$4.4M3831%N/A
#4
$7.5M380%N/A
#5
$4M3819%$18M